Coleman Health Services
Coleman Health Services is an addiction treatment facility at 3920 Lovers Lane in Ravenna, Ohio, offering partial hospitalization or residential treatment, outpatient treatment, and medication-assisted treatment, according to its SAMHSA FindTreatment.gov listing as of November 5, 2026. The same record also lists opioid treatment medications. Payment options listed in the record include Cash or self-payment, Federal, or any government funding for substance use treatment programs, Medicaid, and Medicare. The directory lists 330-673-1347 as the facility's phone number. All details on this page come from that federal record and should be confirmed directly with the facility.
3920 Lovers Lane, Ravenna, OH, 44266
Contact & Location
Address: 3920 Lovers Lane, Ravenna, OH, 44266
Phone: 330-673-1347
Website: https://www.colemanservices.org
Services & Programs
Treatment Types
- Opioid Medication Service Components
- Opioid Treatment Medications
- Outpatient
- Partial Hospitalization / Residential
- Substance Use Medication-Assisted Treatment
Insurance & Payment
- Cash or self-payment
- Federal, or any government funding for substance use treatment programs
- Medicaid
- Medicare
- SAMHSA funding/block grants
- State-financed health insurance plan other than Medicaid
Languages & Accessibility
- Sign language services for the deaf and hard of hearing
Other facilities in Ravenna
- Northeast Ohio VA Healthcare System
330-296-3641 - Stepping Stone Community Service
330-577-4099
Other facilities in Ohio
- BayMark Health Services of Ohio Inc
Kent, OH
330-552-4000 x4261 - BrightView Health
Kent, OH
844-707-7775 - Townhall II
Kent, OH
330-678-3006
Levels of care this record lists, across Ohio: Residential · Medication-Assisted Treatment · Outpatient · Partial Hospitalization (PHP)
Need Help Deciding?
Contact Coleman Health Services directly at 330-673-1347, or call the SAMHSA National Helpline for free, confidential referrals 24/7.
SAMHSA Helpline: 1-800-662-HELPLast checked against FindTreatment.gov: November 5, 2026.